This Week in Dermatology — Jun 20, 2026

Welcome to This Week in Dermatology. This week we're covering nine notable papers spanning clinical screening strategies, advanced therapeutics for severe autoimmune and inflammatory conditions, and emerging prognostic models in patient care. Let's dive in.

This week's papers:

1. Outcomes of dermatologist-performed skin cancer screening in an academic setting: a retrospective cohort study.. Journal of the American Academy of Dermatology 2026
2. Cobratide injection vs Pregabalin for Moderate-to-Severe Acute Herpes Zoster Neuralgia: A Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Exploratory Trial.. Journal of the American Academy of Dermatology 2026
3. OX40 pathway inhibition and Kaposi sarcoma: An emerging safety signal in atopic dermatitis.. Journal of the European Academy of Dermatology and Venereology 2026
4. Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study.. Journal of the American Academy of Dermatology 2026
5. Diagnosis and management of acyclovir-resistant herpes simplex virus for the dermatologist.. Journal of the American Academy of Dermatology 2026
6. Autoimmune Disease in Central Centrifugal Cicatricial Alopecia: A Multi-Institutional Cross-Sectional Study.. Journal of the American Academy of Dermatology 2026
7. Barbed Suture-Assisted High-Tension Cutaneous Closure: Brief Report of 493 Surgical Defects.. Journal of the American Academy of Dermatology 2026
8. Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.. The Journal of investigative dermatology 2026
9. Prognostic prediction models for psoriatic arthritis in psoriasis: A systematic review.. Journal of the European Academy of Dermatology and Venereology 2026

Listen at AudioScholar